Citation Impact
Citing Papers
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
2022
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Global burden of liver disease: 2023 update
2023 Standout
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
2017
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Inflammation in obesity, diabetes, and related disorders
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Diabetic nephropathy – is this an immune disorder?
2017
Works of Jibo Han being referenced
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)
2017
Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
2015
MD2 Blockage Protects Obesity‐Induced Vascular Remodeling via Activating AMPK/Nrf2
2017